Long intergenic non-protein coding RNA 1645 (LINC01645)

Long intergenic non-protein coding RNA 1645 (LINC01645) is a human gene that encodes a long non-coding RNA (lncRNA), more specifically classified as a long intergenic non-protein coding RNA (lincRNA)[1]. LincRNAs are a subclass of lncRNAs that are transcribed from genomic regions located between protein-coding genes and do not overlap them. These molecules do not code for proteins but have been shown to play critical roles in the regulation of gene expression at multiple levels, including chromatin modification, transcriptional, and post-transcriptional processes[4][5]. LincRNAs can act as scaffolds for chromatin-modifying complexes, serve as molecular sponges for microRNAs, influence mRNA decay, and control translation of specific mRNAs, among other regulatory activities[4][5]. While some lincRNAs have established functions in processes such as cell proliferation, differentiation, and disease (including various cancers, fibrosis, and immune responses), there is currently no published functional characterization specifically for LINC01645 in major biological pathways or diseases[1][4]. Its expression, molecular partners, and potential therapeutic relevance remain uncharacterized, making it unlikely to be considered a therapeutic target at this time. Note: Most available data on lincRNAs, including LINC01645, are derived from large-scale transcriptomic surveys and bioinformatics databases; detailed experimental studies on individual lincRNAs are often lacking[1][4][5]. Based on current knowledge, LINC01645 is correctly named, available in gene databases, and is a representative intergenic lncRNA, but is not a validated therapeutic target and has no known drug or biomarker applications[1][4].

Other names

LINC01645ENST00000451341.1